New research shows that a combination of two immune-system factors could open up new avenues for treating diabetes and obesity.
Type 2 Diabetes
U-M researchers show more adults with diabetes covered after ACA provisions for pre-existing conditions and older adults began.
A clinical trial found amlexanox to be potentially helpful in treating type 2 diabetes. But more work is needed before patient application.